Prevalence of self-reported neuropathic pain and impact on quality of life: A prospective representative survey

Acta Anaesthesiologica Scandinavica

Volumn 52, Issue 1, 2008, Pages 132-136

  Gustorff, B ^a,e   Dorner, T ^a   Likar, R ^b   Grisold, W ^c   Lawrence, K ^a   Schwarz, F ^d   Rieder, A ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b GENERAL HOSPITAL KLAGENFURT   (Austria)

^c KAISER FRANZ JOSEF HOSPITAL   (Austria)

^d VIENNA INSTITUTE OF DEMOGRAPHY   (Austria)

^e UNIVERSITY OF VIENNA   (Austria)

Author keywords

Austria; Chronic pain; Neuropathic pain; Prevalence; Quality of life

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT;

ACUPUNCTURE; ADOLESCENT; ADULT; AGED; ANXIETY; ARTICLE; AUSTRIA; CHINESE MEDICINE; DEPRESSION; DISEASE SEVERITY; FEMALE; HEALTH SURVEY; HOMEOPATHY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NEUROPATHIC PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RATING SCALE; SELF REPORT; SLEEP DISORDER; UNITED KINGDOM; VALIDATION STUDY;

ABSENTEEISM; ACTIVITIES OF DAILY LIVING; ADULT; AGED; ANALGESICS; AUSTRIA; CHRONIC DISEASE; COMBINED MODALITY THERAPY; DEPRESSION; FEAR; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; NEURALGIA; PATIENT ACCEPTANCE OF HEALTH CARE; PHYSICAL THERAPY MODALITIES; PREVALENCE; PROSPECTIVE STUDIES; QUALITY OF LIFE; SLEEP DISORDERS, INTRINSIC;

EID: 37549032556     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2007.01486.x     Document Type: Article

References (17)

1. Breivik H, Collett B, Ventafridda V et al. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 2005 10 (4) : 287 333.
2. Katz N. The impact of pain management on quality of life. J Pain Symptom Manage 2002 24 : S38 47.
3. Torrance N, Smith BH, Bennett MI et al. The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain 2006 7 (4) : 281 9.
4. Nicholson B, Verma S. Comorbidities in chronic neuropathic pain. Pain Med 2004 5 : 9 27.
5. Jensen TS, Baron R. Translation of symptoms and signs into mechanisms in neuropathic pain. Pain 2003 102 (1-2) : 1 8.
6. Finnerup NB, Otto M, McQuay HJ et al. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005 118 (3) : 289 305.
7. Gustorff B, Nahlik G, Spacek A et al. Gabapentin in the treatment of chronic intractable pain. Schmerz 2002 16 : 9 14.
8. Bennett M. The LANSS pain scale: the Leeds assessment of neuropathic symptoms and signs. Pain 2001 92 : 147 57.
9. Krause SJ, Backonja M. Development of a neuropathic pain questionnaire. Clin J Pain 2003 19 : 306 14.
10. Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract 2000 47 (2) : 123 8.
11. Bouhassira D, Attal N, Fermanian J et al. Development and validation of the Neuropathic Pain Symptom Inventory. Pain 2004 108 : 248 57.
12. Bouhassira D, Attal N, Alchaar H et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005 114 : 9 36.
13. Helgason S, Petursson G, Gudmundsson S et al. Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up. BMJ 2000 321 : 794 6.
14. Schmader KE. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain 2002 18 (6) : 350 4.
15. Beiske AG, Pedersen ED, Czujko B et al. Pain and sensory complaints in multiple sclerosis. Eur J Neurol 2004 11 (7) : 479 82.
16. Ehde DM, Gibbons LE, Chwastiak L et al. Chronic pain in a large community sample of persons with multiple sclerosis. Mult Scler 2003 9 (6) : 605 11.
17. Hall GC, Carroll D, Parry D et al. Epidemiology and treatment of neuropathic pain: the UK primary care perspective. Pain 2006 122 (1-2) : 156 62.